# FDA Inspection 762574 - American Red Cross - January 11, 2012

Source: https://www.keypedia.com/records/fda_inspections/american-red-cross/7032fe19-bb4f-48e0-a9af-9d5ef4862bec
Source feed: FDA_Inspections

> FDA Inspection 762574 for American Red Cross on January 11, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 762574
- Company Name: American Red Cross
- Inspection Date: 2012-01-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1028818 - 2017-10-05](https://www.keypedia.com/records/fda_inspections/american-red-cross/87e739db-3ecf-41ee-be70-f5338f9dff5d)
- [FDA Inspection 948639 - 2015-11-04](https://www.keypedia.com/records/fda_inspections/american-red-cross/0a599036-ff93-47e2-bdbc-32b00161248d)
- [FDA Inspection 864037 - 2014-01-30](https://www.keypedia.com/records/fda_inspections/american-red-cross/26635db0-51d0-4bfa-a751-8c58ce339dfa)
- [FDA Inspection 652364 - 2010-03-18](https://www.keypedia.com/records/fda_inspections/american-red-cross/fd6ae03c-373c-437e-be3f-fce168f9420b)

Company: https://www.keypedia.com/companies/american-red-cross/1e4ffe57-e30c-4180-bc35-12c523b3df27

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d